Your SlideShare is downloading. ×
  • Like
MRUN India Presentation by Aagami
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.


Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

MRUN India Presentation by Aagami


Connecting Midwest High Tech Startups With India …

Connecting Midwest High Tech Startups With India

MRUN Conf - Oct 12, 2012

Presentation by - Dinesh Jain, Founder CEO, Aagami Inc.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads


Total Views
On SlideShare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. Connecting Midwest High Tech Startups With India MRUN Conf - Oct 12, 2012 Dinesh Jain, Founder CEO Aagami, Inc. …LifeSciences Catalyst
  • 2. Topics covered India – an Introduction IN Lifesciences Industry snapshot Major centers of Lifesciences in India Major Deals and Investments showing  India as a Market Place  India as a Resource Place What Indian LS firms are looking for How Aagami Supports Companies Lifesciences Catalyst 2
  • 3. India – a Brief Introduction (V-IMP)Nation of 1.22 Billion people (~EU+Africa) 28 States and 7 Union Territories 22 Official languages – English is widespreadAncient Civilization – Young Nation Most Heterogeneous and complex Very Traditional Yet quite Modern Last 20 years GDP CAGR at ~7%3rd Largest economy of the world in PPP (IMF) Sizeable # of Rich, yet average person very poor Sci, Tech and Business excel, poor Infrastructure Lifesciences Catalyst 3
  • 4. Indian LS Industry Snapshot 3rd Largest Pharma market (by volume) LS Market ~ $25B, Healthcare ~ $65B Over 20,000 Pharma/BT companies Top 20 Companies have presence in Regulated markets (US, Canada, Western EU and Japan) Top 100 companies are present in 50+ countries Globally successful in Generics “Every 3rd pill in the world is Made in India” Medicine Source of the developing world WHO sources over 70% from India Largest # of US FDA approved mfg facilities Lifesciences Catalyst 4
  • 5. Indian LS Industry Snapshot…cntd Biotech Industry with exploding growth Largest pool of Chemists and Biologists Abundant specialty health institutions  14000+ Hospitals, 700,000+ Beds Large Pool of Medical professionals  ~200 Medical Colleges graduating 30,000+ doctors per year  600,000+ Doctors  Largest pool of Biosciences Graduates Per annum - 3 Million B.S., 700,000 M.S., 15000 Ph Ds  Indian Regulation – a Super Set of US-FDA All Technical & Business work in English Lifesciences Catalyst 5
  • 6. Major Centers of LS Business City – Major Companies Mumbai – Sun, Lupin,Wockhardt, Glenmark, USV, Piramal, Ipca, Most MNCs Ahmedabad – Zydus, Intas, Cadila, Torrent  Hyderabad – Dr. Reddy’s, Aurobindo, Suven, Divi’s, Hetero, Shantha, Bharat  Bengaluru – Biocon, Micro, Strides, GSK,  New Delhi – Ranbaxy, Panacea, Jubilant  Chennai – Orchid, Shasun, Tablets India,  Pune – Bilcare, Serum India, Advinus, Lifesciences Catalyst 6
  • 7. Major Centers of LS Research City – Research Institutes  New Delhi – ICPO, IGIB, TERI, ICGEB, IofPath, NIMS, NIMR, NIPGR,  Hyderabad – ICRISAT, CCMB, IICT, CDFD, ILS, LVP Eye, NCLAS, NIN, ISB,  Pune – NCL, Agarkar, Micobial Complex, NARI, NCCS, NIV, Mumbai – TIFR, BARC, Genetic RC, ICT, Ahmedabad – NIPER, NIOH, NSD, IIM, Bengaluru – IISc, NCBS, IBioInfoABio, Kolkata – Guha CGEB, IICB, NICED, Chennai – Biosys BT, CLRI, NIE, TBRC, Nagpur – ICAR, CI Cotton R, NEERI, NIIPM, NRCC Lucknow – CDRI, CI Med & A Plants, IIToxR, NBRI, Lifesciences Catalyst 7
  • 8. Major Intl Deals and Investments  Wockhardt – Morton Grove, IL  Sun – Caraco, MI, & Taro Israel  Dr. Reddy’s – BetaPharm, DowPharma, BASF  Lupin – Kyowa, Japan  Piramal – Design Resource Group, MA  DaiIchi Sankyo – Ranbaxy  Abbott – Piramal Pharma (Shifting generic mfg)  Sanofi – Shantha Biotech  GSK – Large R&D center  Fresinius Kabi – Large Development Center  Merck, Estellas, Takeda, Biogen, Amgen, started Lifesciences Catalyst 8
  • 9. Latest Relevant News …. Oct 11 – Pharma industry creates 2nd most # of billionaires Oct 7 - India US announce Jt Research in BT Oct 5 – Takeda in $90 M Discovery deal with Advinus Sep 30 – DBT and ABLE roadmap for a $125B by 2025 Biotech industry from $4B in 2011 Sep 14 – Piramal to launch own innovative drug in EU Sep 12 – Panacea forms JV with US’ Osmotica Jul 4 – Serum acquires Dutch firm Bithoven for $100M Jul 2 – AstraZeneca & Cellworks to design TB therapies Jun 20 – Novozymes & Praj to jtly develop Biofuels Jun 4 – Abbott sets Nutri research center with Biocon Apr 21 – Merck to set up $150M vaccine lab in Delhi Apr 16 – Piramal acquires Imaging R&D portfolio of Bayer Lifesciences Catalyst 9
  • 10. Indian Firms are looking for Partnerships, Investment, Licensing or Acquisitions of Innovative compounds and technologies Co-Development Opportunities Novel Drug Delivery Systems  Manufacturing in IN and the US Companies in Regulated markets Lifesciences Catalyst 10
  • 11. Aagami Consulting Services offer  In-Licensing or Out-Licensing  Co-Development and Partnerships  Mergers & Acquisitions  Investments to and from India  Finding the Right  JV partners and/or Distributors  CRO and CRAMS providers  Contract Sales/Marketing companies  Contract Manufacturing companies Lifesciences Catalyst 11
  • 12. Aagami brings Extensive Operational Experience Globally Deep Understanding of business and socio- cultural differences in ways of working Extensive network with top 100 Indian LS companies at CXO levels Deal experience with Western, Japanese and Indian industry Dedicated team with focus on Client success Lifesciences Catalyst 12
  • 13. Business Cultural Differences sample Phrases and points in the US vs IN •As Soon as Possible : ASAP vs ASAP • Tomorrow : Next day vs In near future • Will be done : surely be done vs will try best • Business focus : Specialist vs Generalist • Work driven by : Process vs Ad Hoc • Everyday working : MBO vs MBC • Business Xaction : Contractual vs Trust base • Importance : Transaction vs RelationshipConfidential Lifesciences Catalyst 13
  • 14. Sample List of Aagami Clients USA International Dow - MI  Solvay - Belgium Aegis – CA  Delmar - Canada Advangene – IL  SOM Biotech - Spain MacuCLEAR – TX  Phosphagenics - Australia DesignMedix – OR  NanoSensing - Brazil Unitech Pharma – MI  Affitech - Denmark Loyola U Chicago – IL  Ilsan Ilvac - Turkey MW Univ. – IL, AZ  Pieris - Germany PLx - TX  Toppan – Japan Lifesciences Catalyst 14
  • 15. Our Approach Prepare ‘Elevator Pitch’ on client technology and/or company customized to Specific business culture for e.g. India, Japan Identify Relevant Companies from our Database and resources Broadcast EP to Relevant Companies by email Follow-up with phone calls and emails with all Coordinate CDAs with interested Companies, and supply further info thru emails and conference calls Organize a road show to India along with client representative/s Take appointments with right executives in interested companies Coordinate the logistics of the road show (v imp) Support in structuring and negotiations for finalizing the deal(s) Lifesciences Catalyst 15
  • 16. Realizing Possibilities with Aagami, Inc. 2020 Calamos Ct, Suite 209 Naperville, IL 60564 Phone: (630) 799-1572 Lifesciences Catalyst 16